Are you Dr. Moore?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 75 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 NE 10th St
Oupb5200
Oklahoma City, OK 73104Phone+1 405-271-7770- Is this information wrong?
Summary
- Dr. Kathleen Moore, MD is an obstetrician/gynecologist in Oklahoma City, Oklahoma. She is currently licensed to practice medicine in Oklahoma and Pennsylvania. She is affiliated with OU Health, SSM Health St. Anthony Hospital - Oklahoma City, and INTEGRIS Baptist Medical Center.
Education & Training
- UPMC Medical EducationResidency, Obstetrics and Gynecology, 2000 - 2004
- University of Washington School of MedicineClass of 2000
Certifications & Licensure
- OK State Medical License 2004 - 2025
- PA State Medical License 2001 - 2004
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers Start of enrollment: 2008 Jul 01
- Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer Start of enrollment: 2011 Jun 06
- Safety Study of X-82 in Patients With Advanced Solid Tumors Start of enrollment: 2011 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Developing a novel image marker to predict the clinical outcome of neoadjuvant chemotherapy (NACT) for ovarian cancer patients.Ke Zhang, Neman Abdoli, Patrik Gilley, Youkabed Sadri, Xuxin Chen, Theresa C Thai, Lauren Dockery, Kathleen Moore, Robert S Mannel, Yuchen Qiu> ;Computers in Biology and Medicine. 2024 Feb 27
- Evaluating the Effectiveness of 2D and 3D CT Image Features for Predicting Tumor Response to Chemotherapy.Neman Abdoli, Ke Zhang, Patrik Gilley, Xuxin Chen, Youkabed Sadri, Theresa Thai, Lauren Dockery, Kathleen Moore, Robert Mannel, Yuchen Qiu> ;Bioengineering. 2023 Nov 20
- 1 citationsA phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Craft...> ;International Journal of Gynecological Cancer. 2023 Sep 4
- Join now to see all
Press Mentions
- After Clovis Pulls Third-Line Indication, What Is Rucaparib’s Future for Ovarian Cancer?July 27th, 2022
- VBL Therapeutics to Host in-Person Key Opinion Leader Seminar on Ovarian CancerMarch 31st, 2022
- Is First-Line Maintenance Underused in Advanced Ovarian Cancer?March 20th, 2022
- Join now to see all
Hospital Affiliations
- INTEGRIS Baptist Medical CenterOklahoma City, Oklahoma
- OU HealthOklahoma City, Oklahoma
- SSM Health St. Anthony Hospital - Oklahoma CityOklahoma City, Oklahoma
- OU Medical Center EdmondEdmond, Oklahoma